NASDAQ: JYNT · Real Estate & Construction · 5 alerts · CIK 1612630
Share price
$6.66Close, Nov 16
Market cap
$91.2M
Shares outstanding
13.69MLatest SEC cover page
Sector
Real Estate & Construction
Industry
Patent Owners & LessorsSIC 6794
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Joint Corp filings on SEC EDGAR ↗
Joint 10% Owner Charles E. Jobson Buys $18.8K of Stock
Charles E. Jobson, 10% Owner, bought 2,825 shares of Joint Corp at $6.65 a share, worth $18.8K in total on Nov 10, 2026. Shares held after the trade: 20,322,974 (+0.0%).
Joint 10% Owner Charles E. Jobson Buys $1.57M of Stock
Charles E. Jobson, 10% Owner, bought 236,116 shares of Joint Corp at $6.65 a share, worth $1.57M in total on Nov 9, 2026. Shares held after the trade: 2,030,149 (+13.2%).
The Joint Corp. reported a significant decrease in total assets from $61.0 million at year-end 2025 to $40.7 million as of September 30, 2026, primarily driven by a reduction in discontinued operations assets. The company is executing a strategic shift to refranchise its company-owned clinics and expects a volatile macroeconomic environment to persist through the remainder of 2026.
The Joint Corp. reported Q3 2026 revenue of $13.6 million and net income from continuing operations of $1.5 million. The Board of Directors also authorized an additional $5.0 million for its stock repurchase program, following $3.8 million in repurchases during the quarter.
“Our third quarter results reflect growth in our active membership cou”
Sanjiv Razdan, President and Chief Executive Officer
Joint Signs $8M M&A Deal with The Joint Franchises Texas, Ltd.
The Joint Corp. entered into an Asset Purchase Agreement to reacquire regional development rights in the Texas region from several affiliated entities for $8.0 million in cash. The deal includes the termination of existing regional developer agreements covering 141 franchised clinics and provides for up to $2.0 million in additional performance-based consideration over two years.